-
Heads up for reproductive health and family planning clinics in California and Nevada: The Female Health Co.'s free FC2 Female Condom Experience Program is headed your way. Deadline for applications from clinics in the two states is Aug. 31, 2010, says Rebecca Kizaric, training manager for the Chicago-based company.
-
For 50 years, women have had a reliable form of birth control in the form of the combined oral contraceptive pill. What has emerged in the same time period for men?
-
Research indicates that women are at risk for heightened HIV infection during pregnancy, but what about their partners?
-
Clinicians face challenges when it comes to detecting ovarian cancer: 70% of women with ovarian cancer are diagnosed with advanced disease.
-
Strive to keep your practice up-to-date in 2010 with the publication of the U.S. Medical Eligibility Criteria for Contraceptive Use.
-
Add current data to your clinical knowledge base: the Advisory Committee on Immunization Practices (ACIP) has issued updated recommendations for routine and catch-up vaccination of females with the bivalent or quadrivalent human papillomavirus vaccines (HPV2, HPV4), as well as published its policy statement and summarized background data on use of the HPV4 vaccine in males.
-
An approach designed to reduce HIV and sexually transmitted diseases (STDs) in adolescents previously used exclusively by academic researchers now has been shown to be successfully implemented by community-based organizations (CBOs).
-
An analysis presented at the 2010 National STD Prevention Conference gives a chilling look at impact of HIV and syphilis among U.S. gay and bisexual men.
-
Several descriptive phrases are now being coined when family planning providers discuss such highly effective reversible methods as intrauterine contraception (ParaGard Copper T 380A intrauterine device, Duramed Pharmaceuticals, and the Mirena levonorgestrel intrauterine system, Bayer HealthCare Pharmaceuticals) and the contraceptive implant (Implanon, Schering-Plough Corp.).
-
With drug manufacturers retreating in recent years from voluntary discounts to family planning and other public clinics, providers increasingly rely on federally mandated discounts.